China NMPA Inspection - Zhuji Best Daily Chemical Co., Ltd. - August 30, 2019

The National Medical Products Administration (NMPA), operating under the regulatory framework of the China Drug Administration, issued a notification concerning an unannounced inspection conducted at Zhuji Best Daily Chemical Co., Ltd. This official notification, identified by index number JGXX-2020-2512, was publicly released on August 30, 2019. The title, "Notification of Unannounced Inspection of Zhuji Best Daily Chemical Co., Ltd.," clearly indicates the nature of the regulatory action taken by the NMPA.

The purpose of this notification is to officially communicate that Zhuji Best Daily Chemical Co., Ltd. has been subjected to a surprise regulatory review. However, the provided document itself is solely a notice of this event. It does not contain specific information about the exact dates the inspection was carried out, any main violations or non-compliance issues identified during the review, or any mandated corrective or required actions that the company must undertake. Consequently, this notification serves as a record of regulatory activity rather than a detailed report of inspection findings. Further specifics regarding the outcomes of the unannounced inspection would typically be disseminated through a separate, more comprehensive report or official communication, which is not included in this particular document. This highlights the NMPA's proactive role in monitoring and ensuring compliance within the daily chemical sector.